Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis

被引:57
作者
El-Barbary, Amal M. [1 ]
Hussein, Manal S. [1 ]
Rageh, Elsayed M. [1 ]
Hamouda, Hala E. [2 ]
Wagih, Ayman A. [2 ]
Ismail, Raghda G. [3 ]
机构
[1] Tanta Univ, Fac Med, Dept Rheumatol, Tanta, Egypt
[2] Tanta Univ, Fac Med, Dept Med Biochem, Tanta, Egypt
[3] Tanta Univ, Fac Med, Dept Cardiol, Tanta, Egypt
关键词
RHEUMATOID ARTHRITIS; ATORVASTATIN; ADIPOKINES; BRACHIAL ARTERY FLOW-MEDIATED DILATION; CORONARY-ARTERY-DISEASE; HMG-COA REDUCTASE; ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; SYNOVIAL-FLUID; PLASMA-LEVELS; TNF-ALPHA; ADIPONECTIN;
D O I
10.3899/jrheum.100582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the effect of atorvastatin therapy on inflammation, disease activity, endothelial dysfunction, and arterial stiffness in patients with rheumatoid arthritis (RA). Methods. This study included 30 patients with early RA, randomly divided into 2 groups. Group 1 (n = 15) received methotrexate (MTX; 0.2 mg/kg/week; mean (15.5 +/- SD 1.3) plus prednisone (10 mg/day). Group 2 (n = 15) received MTX and prednisone with the same previous doses plus atorvastatin therapy (40 mg/day). Ten healthy individuals of similar age and sex served as controls. Disease activity, lipid profile, serum malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-alpha), resistin, adiponectin, and brachial artery flow-mediated dilation (FMD) were measured before and after 6 months of treatment. Results. Atorvastatin combined with MTX therapy significantly reduced serum total cholesterol, low-density lipoprotein cholesterol, and triglycerides, and increased high-density lipoprotein cholesterol (p < 0.001). Disease activity variables, serum MDA. TNF-alpha, resistin, adiponectin, and FMD were significantly improved by the drug combinations (p < 0.001). Conclusion. Atorvastatin therapy in patients with RA reduced disease activity and conventional and novel vascular risk factors that promote the atheromatous lesion. Therapy was also associated with concomitant improvement in endothelial function. (First Release Nov 1 2010; J Rheumatol 2011;38:229-35; doi: 10.3899/jrheum.100582)
引用
收藏
页码:229 / 235
页数:7
相关论文
共 52 条
[11]   Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans [J].
Bruun, JM ;
Lihn, AS ;
Verdich, C ;
Pedersen, SB ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E527-E533
[12]   NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[13]   Serum resistin in gestational diabetes mellitus and early postpartum [J].
Chen, Danqing ;
Fang, Qin ;
Chai, Yun ;
Wang, Hanzhi ;
Huang, Hefeng ;
Dong, Minyue .
CLINICAL ENDOCRINOLOGY, 2007, 67 (02) :208-211
[14]   Plasma resistin associated with myocardium injury in patients with acute coronary syndrome [J].
Chu, Songyun ;
Ding, Wenhui ;
Li, Kang ;
Pang, Yongzheng ;
Tang, Chaoshu .
CIRCULATION JOURNAL, 2008, 72 (08) :1249-1253
[15]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[16]   Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy [J].
Danesh, FR ;
Kanwar, YS .
FASEB JOURNAL, 2004, 18 (07) :805-815
[17]   Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients [J].
Georgiadis, Athanasios N. ;
Voulgari, Paraskevi V. ;
Argyropoulou, Maria I. ;
Alamanos, Yannis ;
Elisaf, Moses ;
Tselepis, Alexandros D. ;
Drosos, Alexandros A. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (01) :13-19
[18]   Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study [J].
Georgiadis, Athanasios N. ;
Papavasiliou, Eleni C. ;
Lourida, Evangelia S. ;
Alamanos, Yannis ;
Kostara, Christina ;
D Tselepis, Alexandros ;
Drosos, Alexandros A. .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (03)
[19]  
Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505
[20]  
HADDA V., 2007, Indian J ofRheu, V2, P137